gal 3bp elisa kit Search Results


human galectin-3bp/mac-2bp quantikine elisa kit  (Bio-Techne corporation)
93
Bio-Techne corporation human galectin-3bp/mac-2bp quantikine elisa kit
Human Galectin 3bp/Mac 2bp Quantikine Elisa Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gal+3bp+elisa+kit/Human+Galectin-3BP%2FMAC-2BP+Quantikine+ELISA+Kit/bio-techne+corporation___dgbp30b
Average 93 stars, based on 1 article reviews
human galectin-3bp/mac-2bp quantikine elisa kit - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
lgals3bp  (Boster Bio)
90
Boster Bio lgals3bp
Lgals3bp, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gal+3bp+elisa+kit/Human+Galectin-3BP+ELISA+Kit+PicoKine/pm40691443-341-27-28
Average 90 stars, based on 1 article reviews
lgals3bp - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
lgals3bp  (R&D Systems)
93
R&D Systems lgals3bp
( A ) Schematic for detecting differentially expressed ECM proteins that also showed differential secretion in lipid-loaded human vascular SMCs. ( B ) The proteomics analysis of the conditioned media (“secretome”) showed the <t>LGALS3BP</t> level to be significantly higher in the lipid-loaded versus control SMCs ( n = 6, *** P = 0.005, paired t test). The box plot is as follows: black line, median; box edges, 1st and 3rd quartile; whiskers, furthest point within 1.5 times the interquartile range. ( C ) Immunofluorescence staining for LGALS3BP (red) in early atherosclerosis (human ascending aorta). Autofluorescence of elastin fibers (green). Scale bars: 200 μm. ( D ) Validation by immunoblotting. Note the co-detection of MMP9, FN1, LGALS3BP, and TNC upon lipid loading. SMCs from two different donors. Gelatin zymography for MMP2 was used as loading control. ( E ) Human aortic explants were either incubated with 50 pM MMP9 or left untreated for 24 hours. The degradation of FN1, TNC, and LGALS3B was examined by immunoblotting. MMP9 induces degradation of FN1 and TNC but releases LGALS3BP from human aortic explants. Aortic explants were from 2 different donors. Arrows indicate fragmentation products.
Lgals3bp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gal+3bp+elisa+kit/Human+Galectin-3BP%2FMAC-2BP+Quantikine+ELISA+Kit/pmc05373893-296-35-37
Average 93 stars, based on 1 article reviews
lgals3bp - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
adeno-quest kit  (Quantum Biotechnologies Inc)
90
Quantum Biotechnologies Inc adeno-quest kit
( A ) Schematic for detecting differentially expressed ECM proteins that also showed differential secretion in lipid-loaded human vascular SMCs. ( B ) The proteomics analysis of the conditioned media (“secretome”) showed the <t>LGALS3BP</t> level to be significantly higher in the lipid-loaded versus control SMCs ( n = 6, *** P = 0.005, paired t test). The box plot is as follows: black line, median; box edges, 1st and 3rd quartile; whiskers, furthest point within 1.5 times the interquartile range. ( C ) Immunofluorescence staining for LGALS3BP (red) in early atherosclerosis (human ascending aorta). Autofluorescence of elastin fibers (green). Scale bars: 200 μm. ( D ) Validation by immunoblotting. Note the co-detection of MMP9, FN1, LGALS3BP, and TNC upon lipid loading. SMCs from two different donors. Gelatin zymography for MMP2 was used as loading control. ( E ) Human aortic explants were either incubated with 50 pM MMP9 or left untreated for 24 hours. The degradation of FN1, TNC, and LGALS3B was examined by immunoblotting. MMP9 induces degradation of FN1 and TNC but releases LGALS3BP from human aortic explants. Aortic explants were from 2 different donors. Arrows indicate fragmentation products.
Adeno Quest Kit, supplied by Quantum Biotechnologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gal+3bp+elisa+kit/adeno+quest+kit/us07790690-300-12-17
Average 90 stars, based on 1 article reviews
adeno-quest kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
human galectin-3bp/mac-2bp duoset elisa  (Bio-Techne corporation)
94
Bio-Techne corporation human galectin-3bp/mac-2bp duoset elisa
( A ) Schematic for detecting differentially expressed ECM proteins that also showed differential secretion in lipid-loaded human vascular SMCs. ( B ) The proteomics analysis of the conditioned media (“secretome”) showed the <t>LGALS3BP</t> level to be significantly higher in the lipid-loaded versus control SMCs ( n = 6, *** P = 0.005, paired t test). The box plot is as follows: black line, median; box edges, 1st and 3rd quartile; whiskers, furthest point within 1.5 times the interquartile range. ( C ) Immunofluorescence staining for LGALS3BP (red) in early atherosclerosis (human ascending aorta). Autofluorescence of elastin fibers (green). Scale bars: 200 μm. ( D ) Validation by immunoblotting. Note the co-detection of MMP9, FN1, LGALS3BP, and TNC upon lipid loading. SMCs from two different donors. Gelatin zymography for MMP2 was used as loading control. ( E ) Human aortic explants were either incubated with 50 pM MMP9 or left untreated for 24 hours. The degradation of FN1, TNC, and LGALS3B was examined by immunoblotting. MMP9 induces degradation of FN1 and TNC but releases LGALS3BP from human aortic explants. Aortic explants were from 2 different donors. Arrows indicate fragmentation products.
Human Galectin 3bp/Mac 2bp Duoset Elisa, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gal+3bp+elisa+kit/Human+Galectin-3BP%2FMAC-2BP+DuoSet+ELISA/bio-techne+corporation___dy2226
Average 94 stars, based on 1 article reviews
human galectin-3bp/mac-2bp duoset elisa - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
creatinine parameter assay kit  (Bio-Techne corporation)
95
Bio-Techne corporation creatinine parameter assay kit
( A ) Schematic for detecting differentially expressed ECM proteins that also showed differential secretion in lipid-loaded human vascular SMCs. ( B ) The proteomics analysis of the conditioned media (“secretome”) showed the <t>LGALS3BP</t> level to be significantly higher in the lipid-loaded versus control SMCs ( n = 6, *** P = 0.005, paired t test). The box plot is as follows: black line, median; box edges, 1st and 3rd quartile; whiskers, furthest point within 1.5 times the interquartile range. ( C ) Immunofluorescence staining for LGALS3BP (red) in early atherosclerosis (human ascending aorta). Autofluorescence of elastin fibers (green). Scale bars: 200 μm. ( D ) Validation by immunoblotting. Note the co-detection of MMP9, FN1, LGALS3BP, and TNC upon lipid loading. SMCs from two different donors. Gelatin zymography for MMP2 was used as loading control. ( E ) Human aortic explants were either incubated with 50 pM MMP9 or left untreated for 24 hours. The degradation of FN1, TNC, and LGALS3B was examined by immunoblotting. MMP9 induces degradation of FN1 and TNC but releases LGALS3BP from human aortic explants. Aortic explants were from 2 different donors. Arrows indicate fragmentation products.
Creatinine Parameter Assay Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gal+3bp+elisa+kit/Creatinine+Parameter+Assay+Kit/bio-techne+corporation___kge005
Average 95 stars, based on 1 article reviews
creatinine parameter assay kit - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
elisa kit  (Quidel)
95
Quidel elisa kit
( A ) Schematic for detecting differentially expressed ECM proteins that also showed differential secretion in lipid-loaded human vascular SMCs. ( B ) The proteomics analysis of the conditioned media (“secretome”) showed the <t>LGALS3BP</t> level to be significantly higher in the lipid-loaded versus control SMCs ( n = 6, *** P = 0.005, paired t test). The box plot is as follows: black line, median; box edges, 1st and 3rd quartile; whiskers, furthest point within 1.5 times the interquartile range. ( C ) Immunofluorescence staining for LGALS3BP (red) in early atherosclerosis (human ascending aorta). Autofluorescence of elastin fibers (green). Scale bars: 200 μm. ( D ) Validation by immunoblotting. Note the co-detection of MMP9, FN1, LGALS3BP, and TNC upon lipid loading. SMCs from two different donors. Gelatin zymography for MMP2 was used as loading control. ( E ) Human aortic explants were either incubated with 50 pM MMP9 or left untreated for 24 hours. The degradation of FN1, TNC, and LGALS3B was examined by immunoblotting. MMP9 induces degradation of FN1 and TNC but releases LGALS3BP from human aortic explants. Aortic explants were from 2 different donors. Arrows indicate fragmentation products.
Elisa Kit, supplied by Quidel, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gal+3bp+elisa+kit/C3a+Plus+ELISA/pm25013204-128-11-13
Average 95 stars, based on 1 article reviews
elisa kit - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
dneasy blood tissue kit  (Qiagen)
99
Qiagen dneasy blood tissue kit
( A ) Schematic for detecting differentially expressed ECM proteins that also showed differential secretion in lipid-loaded human vascular SMCs. ( B ) The proteomics analysis of the conditioned media (“secretome”) showed the <t>LGALS3BP</t> level to be significantly higher in the lipid-loaded versus control SMCs ( n = 6, *** P = 0.005, paired t test). The box plot is as follows: black line, median; box edges, 1st and 3rd quartile; whiskers, furthest point within 1.5 times the interquartile range. ( C ) Immunofluorescence staining for LGALS3BP (red) in early atherosclerosis (human ascending aorta). Autofluorescence of elastin fibers (green). Scale bars: 200 μm. ( D ) Validation by immunoblotting. Note the co-detection of MMP9, FN1, LGALS3BP, and TNC upon lipid loading. SMCs from two different donors. Gelatin zymography for MMP2 was used as loading control. ( E ) Human aortic explants were either incubated with 50 pM MMP9 or left untreated for 24 hours. The degradation of FN1, TNC, and LGALS3B was examined by immunoblotting. MMP9 induces degradation of FN1 and TNC but releases LGALS3BP from human aortic explants. Aortic explants were from 2 different donors. Arrows indicate fragmentation products.
Dneasy Blood Tissue Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gal+3bp+elisa+kit/DNeasy+Blood+%26+Tissue+Kit/pm41957362-434-32-37
Average 99 stars, based on 1 article reviews
dneasy blood tissue kit - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
msi kit  (Promega)
90
Promega msi kit
( A ) Schematic for detecting differentially expressed ECM proteins that also showed differential secretion in lipid-loaded human vascular SMCs. ( B ) The proteomics analysis of the conditioned media (“secretome”) showed the <t>LGALS3BP</t> level to be significantly higher in the lipid-loaded versus control SMCs ( n = 6, *** P = 0.005, paired t test). The box plot is as follows: black line, median; box edges, 1st and 3rd quartile; whiskers, furthest point within 1.5 times the interquartile range. ( C ) Immunofluorescence staining for LGALS3BP (red) in early atherosclerosis (human ascending aorta). Autofluorescence of elastin fibers (green). Scale bars: 200 μm. ( D ) Validation by immunoblotting. Note the co-detection of MMP9, FN1, LGALS3BP, and TNC upon lipid loading. SMCs from two different donors. Gelatin zymography for MMP2 was used as loading control. ( E ) Human aortic explants were either incubated with 50 pM MMP9 or left untreated for 24 hours. The degradation of FN1, TNC, and LGALS3B was examined by immunoblotting. MMP9 induces degradation of FN1 and TNC but releases LGALS3BP from human aortic explants. Aortic explants were from 2 different donors. Arrows indicate fragmentation products.
Msi Kit, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gal+3bp+elisa+kit/msi+kit/10__1038_slash_modpathol__2011__21-1674-102-101
Average 90 stars, based on 1 article reviews
msi kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
sc5b 9 concentrations  (Quidel)
95
Quidel sc5b 9 concentrations
( A ) Schematic for detecting differentially expressed ECM proteins that also showed differential secretion in lipid-loaded human vascular SMCs. ( B ) The proteomics analysis of the conditioned media (“secretome”) showed the <t>LGALS3BP</t> level to be significantly higher in the lipid-loaded versus control SMCs ( n = 6, *** P = 0.005, paired t test). The box plot is as follows: black line, median; box edges, 1st and 3rd quartile; whiskers, furthest point within 1.5 times the interquartile range. ( C ) Immunofluorescence staining for LGALS3BP (red) in early atherosclerosis (human ascending aorta). Autofluorescence of elastin fibers (green). Scale bars: 200 μm. ( D ) Validation by immunoblotting. Note the co-detection of MMP9, FN1, LGALS3BP, and TNC upon lipid loading. SMCs from two different donors. Gelatin zymography for MMP2 was used as loading control. ( E ) Human aortic explants were either incubated with 50 pM MMP9 or left untreated for 24 hours. The degradation of FN1, TNC, and LGALS3B was examined by immunoblotting. MMP9 induces degradation of FN1 and TNC but releases LGALS3BP from human aortic explants. Aortic explants were from 2 different donors. Arrows indicate fragmentation products.
Sc5b 9 Concentrations, supplied by Quidel, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gal+3bp+elisa+kit/SC5b-9+Plus+ELISA/pm25013204-128-7-13
Average 95 stars, based on 1 article reviews
sc5b 9 concentrations - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
3-markers (mean)  (Promega)
90
Promega 3-markers (mean)
( A ) Schematic for detecting differentially expressed ECM proteins that also showed differential secretion in lipid-loaded human vascular SMCs. ( B ) The proteomics analysis of the conditioned media (“secretome”) showed the <t>LGALS3BP</t> level to be significantly higher in the lipid-loaded versus control SMCs ( n = 6, *** P = 0.005, paired t test). The box plot is as follows: black line, median; box edges, 1st and 3rd quartile; whiskers, furthest point within 1.5 times the interquartile range. ( C ) Immunofluorescence staining for LGALS3BP (red) in early atherosclerosis (human ascending aorta). Autofluorescence of elastin fibers (green). Scale bars: 200 μm. ( D ) Validation by immunoblotting. Note the co-detection of MMP9, FN1, LGALS3BP, and TNC upon lipid loading. SMCs from two different donors. Gelatin zymography for MMP2 was used as loading control. ( E ) Human aortic explants were either incubated with 50 pM MMP9 or left untreated for 24 hours. The degradation of FN1, TNC, and LGALS3B was examined by immunoblotting. MMP9 induces degradation of FN1 and TNC but releases LGALS3BP from human aortic explants. Aortic explants were from 2 different donors. Arrows indicate fragmentation products.
3 Markers (Mean), supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gal+3bp+elisa+kit/3+markers++mean+/10__1038_slash_modpathol__2011__21-1674-76-101
Average 90 stars, based on 1 article reviews
3-markers (mean) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
human galectin-3 quantikine elisa kit  (Bio-Techne corporation)
93
Bio-Techne corporation human galectin-3 quantikine elisa kit
( A ) Schematic for detecting differentially expressed ECM proteins that also showed differential secretion in lipid-loaded human vascular SMCs. ( B ) The proteomics analysis of the conditioned media (“secretome”) showed the <t>LGALS3BP</t> level to be significantly higher in the lipid-loaded versus control SMCs ( n = 6, *** P = 0.005, paired t test). The box plot is as follows: black line, median; box edges, 1st and 3rd quartile; whiskers, furthest point within 1.5 times the interquartile range. ( C ) Immunofluorescence staining for LGALS3BP (red) in early atherosclerosis (human ascending aorta). Autofluorescence of elastin fibers (green). Scale bars: 200 μm. ( D ) Validation by immunoblotting. Note the co-detection of MMP9, FN1, LGALS3BP, and TNC upon lipid loading. SMCs from two different donors. Gelatin zymography for MMP2 was used as loading control. ( E ) Human aortic explants were either incubated with 50 pM MMP9 or left untreated for 24 hours. The degradation of FN1, TNC, and LGALS3B was examined by immunoblotting. MMP9 induces degradation of FN1 and TNC but releases LGALS3BP from human aortic explants. Aortic explants were from 2 different donors. Arrows indicate fragmentation products.
Human Galectin 3 Quantikine Elisa Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gal+3bp+elisa+kit/Human+Galectin-3+Quantikine+ELISA+Kit/custom%40dgal30%4031080833
Average 93 stars, based on 1 article reviews
human galectin-3 quantikine elisa kit - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

Image Search Results


( A ) Schematic for detecting differentially expressed ECM proteins that also showed differential secretion in lipid-loaded human vascular SMCs. ( B ) The proteomics analysis of the conditioned media (“secretome”) showed the LGALS3BP level to be significantly higher in the lipid-loaded versus control SMCs ( n = 6, *** P = 0.005, paired t test). The box plot is as follows: black line, median; box edges, 1st and 3rd quartile; whiskers, furthest point within 1.5 times the interquartile range. ( C ) Immunofluorescence staining for LGALS3BP (red) in early atherosclerosis (human ascending aorta). Autofluorescence of elastin fibers (green). Scale bars: 200 μm. ( D ) Validation by immunoblotting. Note the co-detection of MMP9, FN1, LGALS3BP, and TNC upon lipid loading. SMCs from two different donors. Gelatin zymography for MMP2 was used as loading control. ( E ) Human aortic explants were either incubated with 50 pM MMP9 or left untreated for 24 hours. The degradation of FN1, TNC, and LGALS3B was examined by immunoblotting. MMP9 induces degradation of FN1 and TNC but releases LGALS3BP from human aortic explants. Aortic explants were from 2 different donors. Arrows indicate fragmentation products.

Journal: The Journal of Clinical Investigation

Article Title: Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques

doi: 10.1172/JCI86924

Figure Lengend Snippet: ( A ) Schematic for detecting differentially expressed ECM proteins that also showed differential secretion in lipid-loaded human vascular SMCs. ( B ) The proteomics analysis of the conditioned media (“secretome”) showed the LGALS3BP level to be significantly higher in the lipid-loaded versus control SMCs ( n = 6, *** P = 0.005, paired t test). The box plot is as follows: black line, median; box edges, 1st and 3rd quartile; whiskers, furthest point within 1.5 times the interquartile range. ( C ) Immunofluorescence staining for LGALS3BP (red) in early atherosclerosis (human ascending aorta). Autofluorescence of elastin fibers (green). Scale bars: 200 μm. ( D ) Validation by immunoblotting. Note the co-detection of MMP9, FN1, LGALS3BP, and TNC upon lipid loading. SMCs from two different donors. Gelatin zymography for MMP2 was used as loading control. ( E ) Human aortic explants were either incubated with 50 pM MMP9 or left untreated for 24 hours. The degradation of FN1, TNC, and LGALS3B was examined by immunoblotting. MMP9 induces degradation of FN1 and TNC but releases LGALS3BP from human aortic explants. Aortic explants were from 2 different donors. Arrows indicate fragmentation products.

Article Snippet: In the Bruneck year 2000 evaluation and the SAPHIR study, the following proteins were measured by ELISA in plasma samples according to the manufacturers’ instructions: MMP9 from R&D Systems (DMP900); CHI3L1 from R&D Systems (DC3L10); LGALS3BP from R&D Systems (DGBP30); S100A8/A9 from BMA Biomedicals.

Techniques: Control, Immunofluorescence, Staining, Biomarker Discovery, Western Blot, Zymography, Incubation

( A ) Immunohistochemistry staining for LGALS3BP, S100A8/A9, CHI3L1, and MMP9 plus SMC (SMA, CNN1) and macrophage (CD68) markers. Scale bars: 500 μm. ( B ) Association between the biomarker candidates and atherosclerosis ( n = 560) and CVD ( n = 685) in the Bruneck study. Direction and strength of associations are coded by color and significance levels by size of frames. ORs are derived from logistic regression analysis, and hazard ratios from Cox models. ORs and hazard ratios are expressed for a 1-SD higher log e -transformed level of the given marker. Full details are presented in . Model 1 (M1) was adjusted for age (years) and sex. M2 was additionally controlled for standard vascular risk factors, including LDL cholesterol (mg/dl), HDL cholesterol (mg/dl), high-sensitivity CRP (mg/l), diabetes mellitus (0 vs. 1), hypertension (0 vs. 1), smoking (pack-years), and body mass index (kg/m 2 ). *Additionally adjusted for atherosclerosis score (mm).

Journal: The Journal of Clinical Investigation

Article Title: Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques

doi: 10.1172/JCI86924

Figure Lengend Snippet: ( A ) Immunohistochemistry staining for LGALS3BP, S100A8/A9, CHI3L1, and MMP9 plus SMC (SMA, CNN1) and macrophage (CD68) markers. Scale bars: 500 μm. ( B ) Association between the biomarker candidates and atherosclerosis ( n = 560) and CVD ( n = 685) in the Bruneck study. Direction and strength of associations are coded by color and significance levels by size of frames. ORs are derived from logistic regression analysis, and hazard ratios from Cox models. ORs and hazard ratios are expressed for a 1-SD higher log e -transformed level of the given marker. Full details are presented in . Model 1 (M1) was adjusted for age (years) and sex. M2 was additionally controlled for standard vascular risk factors, including LDL cholesterol (mg/dl), HDL cholesterol (mg/dl), high-sensitivity CRP (mg/l), diabetes mellitus (0 vs. 1), hypertension (0 vs. 1), smoking (pack-years), and body mass index (kg/m 2 ). *Additionally adjusted for atherosclerosis score (mm).

Article Snippet: In the Bruneck year 2000 evaluation and the SAPHIR study, the following proteins were measured by ELISA in plasma samples according to the manufacturers’ instructions: MMP9 from R&D Systems (DMP900); CHI3L1 from R&D Systems (DC3L10); LGALS3BP from R&D Systems (DGBP30); S100A8/A9 from BMA Biomedicals.

Techniques: Immunohistochemistry, Staining, Biomarker Discovery, Derivative Assay, Transformation Assay, Marker